OKYO Pharma Ltd - OKYO
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | History | Reduced | 471,523 | 745 | 0.59% | 3.03% | 1 | -1,950,525 | -80.53% | Q4 2025 | Feb 17, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | History | Added to | 138,000 | 285 | 0.0% | 0.0% | 2 | +96,800 | 234.95% | Q4 2025 | Feb 12, 2026 |
| XTX Topco Ltd | History | New | 17,612 | 36 | 0.0% | — | 3 | +17,612 | New | Q4 2025 | Feb 17, 2026 |
| Cerity Partners LLC | History | No change | 12,812 | 26 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q4 2025 | Feb 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 12,090 | 25 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q4 2025 | Feb 09, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | History | No change | 10,000 | 21 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q4 2025 | Jan 08, 2026 |
| UBS Group AG | History | New | 2,172 | 4 | 0.0% | — | 7 | +2,172 | New | Q4 2025 | Jan 29, 2026 |
| EFG International AG | History | New | 923 | 1 | 0.0% | — | 8 | +923 | New | Q4 2025 | Feb 17, 2026 |
| NORTHERN TRUST CORP | History | Closed out | 0 | 0 | — | 0.0% | — | -57,158 | -100.0% | Q3 2025 | Nov 14, 2025 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -15,355 | -100.0% | Q3 2025 | Nov 14, 2025 |
| MORGAN STANLEY | History | New | 10 | 0 | — | — | — | +10 | New | Q4 2025 | Feb 13, 2026 |
| OSAIC HOLDINGS, INC. | History | No change | 152 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 17, 2026 |